31

Dec2021

PDCI Year in Review

As 2021 comes to an end, PDCI is reflecting on the year we've had in Canadian market access. PDCI's 2021 Year in Review highlights important milestones that occurred in 2021 and looks forward at Trends to Watch in 2022. Click here for the PDF version... Read More

28

Dec2021
Health Canada announced on December 23, 2021 that the coming into force of the Patented Medicines Regulations has been delayed for another 6 months to July 1, 2022. As a result, implementation of the New PMPRB Guidelines (which in part rely on the amended Regulations) are also delayed until July ... Read More

17

Dec2021
PDCI is pleased to announce the release of the 2021 update to the Census of Insurers. The Census of Insurers is available exclusively through the PDCI Market Access Toolkit. PDCI’s Census of Insurers estimates the market share and private covered lives by insurer across Canada. Private payer and access managers ... Read More

17

Dec2021
PDCI releases new issue of PDCI Market Access INSIGHTS, featuring research and opinion on the evolving state of private health insurance in Canada. VOLUME 2, ISSUE 1... Read More

17

Dec2021
On October 28th, 2021, PMPRB provided their first update to the Notice & Comment that was issued on July 15, 2021. The primary takeaway is PMPRB will be providing patentees two reporting periods for compliance, a change from PMPRB's earlier position expecting one reporting period for ... Read More

17

Dec2021
Consultation on the Proposed Framework for a Potential Pan-Canadian Formulary will be open for feedback from January 11 - February 25, 2022.  A discussion paper summarizing the Advisory Panel’s interim recommendations and proposed process will be posted on the CADTH website and CADTH will host an information session on January 18, 2022 at 1 p.m. (ET).  ... Read More

17

Dec2021
On December 16, 2021, CADTH provided an update regarding CADTH’s drug review programs. A. Expanded Provisional Funding Algorithm Process CADTH has expanded the provisional funding algorithm process to include a new rapid algorithm process. This rapid algorithm process will be ... Read More

07

Dec2021
In cancer care, patients often face increased anxiety and uncertainty about their future care pathway. This is paired with an immediate need for therapy to treat potentially aggressive disease. Coverage eligibility for THCD varies significantly across Canadian provinces, creating interprovincial differences. Gaps in coverage of THCDs across provinces lead to inequitable ... Read More

13

Sep2021

Welcome to the PDCI Team

PDCI Welcomes Véronique Scott & Ishan Kumar to the Team Ishan Kumar joins PDCI as Manager, Data Innovation and Insights. As a member of PDCI’s data insights team, Ishan’s role includes designing ... Read More

10

Aug2021
John Anacleto Joins PDCI as Director of Private Payer Strategies & Data Insights Please join us in welcoming John to the PDCI Market Access Family! John joins ... Read More